Consumer Healthcare Products Association
FDANonrulemakingFDA-2018-D-1456

Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-the-Counter Monograph: Study Elements and Considerations; Draft Guidance for Industry; Availability

RIN
Last modified
May 14, 2020
Comment window
closed 2927d ago
Consumer Healthcare Products Association filings
1

Activity

Consumer Healthcare Products Association filed 1 comment on this docket between Jul 25, 2018 and Jul 25, 2018. 0 other organizations filed here. The comment window closed 2927d ago.

What Consumer Healthcare Products Association filed (1)

Jul 25, 2018· Comment from The Personal Care Products Council and the Consumer Healthcare Products Association· FDA-2018-D-1456-0009

To Whom it May Concern: Attached please find a copy of the Personal Care Products Council and Consumer Healthcare Products Association joint comments on Docket No. FDA-2018-D-1456, Draft Guidance on Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an Over-the-Counter Monograph; Study Elements and Considerations. Thank you.

Abstract

No abstract recorded.

View on regulations.gov →